Mepur H Ravindranath
11PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jul 26, 2024
Conformational Alterations of the Cell Surface of Monomeric and Dimeric β2m-Free HLA-I (Proto-HLA) May Enable Novel Immune Functions in Health and Disease.Mepur H Ravindranath, Narendranath M Ravindranath, Carly J Amato-Menker
|Feb 23, 2024
Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity.Mepur H Ravindranath, Narendranath M Ravindranath, Carly J Amato-Menker
|Aug 26, 2023
Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?Mepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan
|Apr 24, 2023
Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment.Mepur H Ravindranath, Narendranath M Ravindranath, Carly J Amato-Menker
|Sep 22, 2022
Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.Mepur H Ravindranath, Fatiha El Hilali, Carly J Amato-Menker
|Mar 24, 2022
Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients.Mepur H Ravindranath, Narendranath M Ravindranath, Fatiha El Hilali
Pageof 2
